Image SHA-256 — metallodrugdb-full-sale.png
d3e7bcf75b2195692aa412da8a153963971b6af358f0daa8ecc71fcb4495ae9f

MetalloDrugDB - Complete Database Acquisition (300 Compounds)

$40M
In stock
SKU
METALLODRUGDB-FULL-SALE

💳 Available Payment Options

Companies can pay via the structures below. Exact amounts and terms are set per item at agreement. Use the calculator to see approximate payments for a given total and term.

Leave blank to use the product price.
Full amount due upon agreement or by agreed date. Best for simpler deals.
Amount Due:

Sign the license agreement and complete payment via wire transfer.

Equal payments monthly (or quarterly for 24+ months).
Payment Amount:
Frequency:
Total Payments:

Sign the license agreement and complete payment via wire transfer.

Upfront fee (20-30%) + % of net revenue, with minimum annual royalty. Paid quarterly.
Upfront Fee:
Remaining (via royalty):

+ % of net revenue quarterly, with minimum annual royalty. Terms set at agreement.

Sign the license agreement and complete payment via wire transfer.

% of gross or net revenue, no/minimal upfront. Good when revenue is more predictable than milestones.
Structure: % of gross or net revenue

No or minimal upfront cost. Percentage and terms set at agreement based on projected revenue.

Sign the license agreement and complete payment via wire transfer.

Payments at key events: signing, delivery, first sale, regulatory approval, etc.
Typical Milestones:
  • Signing
  • Delivery
  • First Sale
  • Regulatory Approval

Amounts allocated per milestone at agreement. Total equals the agreed price.

Sign the license agreement and complete payment via wire transfer.

Fixed fee per year, renewable. Suits ongoing use, updates, or support. Multi-year discounts possible.
Annual Fee:
Discount:
Total over term:

Sign the license agreement and complete payment via wire transfer.

Lump sum due Net 30, Net 60, or Net 90 after agreement or delivery. Single payment, later date.
Amount Due:
Due Date:

Sign the license agreement and complete payment via wire transfer.

The world's first patent-pending[1] database of 300 advanced multi-element pharmaceutical compounds spanning 15 therapeutic categories and 43 elements. Includes U.S. Patent Application 19/630,444, full synthesis data, and scientific validation report. Exclusive acquisition opportunity.
First to market

Publicly online since 2010 · U.S. patent applications since 2012 · inventions offered since 2014. The work of Christopher Gabriel Brown, independently documented.

First posted: · Last updated:
Links
Instant download

Downloads immediately on checkout — the MetalloDrugDB Complete 2026 bundle (AES-256 encrypted, 4.9 MB). Open with 7-Zip, WinRAR, or macOS Archive Utility using password CRIONE99KEY. Bundle contains all 300 compound recipes, patent application 19/630,444, four patent drawings, the cross-reference validation report, and 300 per-disease research files. Patent Assignment and other closing documents (Sale Agreement Article 4) transfer separately upon executed contract — contact the seller for the closing process.

Image disclaimer: Product images are illustrative and may not fully represent this product in complete capacity.

MetalloDrugDB™

The World's First Patent-pending[1] Multi-Element Pharmaceutical Compound Database


What You Are Purchasing

The complete MetalloDrugDB — a proprietary database of 300 advanced multi-element coordination complexes designed for pharmaceutical applications. This is the first and only structured database of metal-based therapeutic compounds in existence.

A 2022 study published in Drug Discovery Today confirmed that no public metallodrug database exists anywhere in the pharmaceutical sciences. MetalloDrugDB fills that gap.


By The Numbers

MetricValue
Total Compounds300
Therapeutic Categories15
Elements Used43
Scientific Cross-Reference Score80-87%
Databases Cross-Referenced10
Patent StatusFiled (U.S. App. No. 19/630,444)
Priority DateMarch 27, 2026

15 Therapeutic Categories

CatCategoryCompounds
AAntimicrobial20
BCardiovascular20
CRespiratory20
DGastrointestinal20
EAnalgesic & Anti-inflammatory20
FEndocrine20
GNeurological20
HDermatological20
IHematologic20
JPsychiatric20
KRenal & Hepatic20
LImmunological20
MMetabolic20
NOncologic Support20
OOphthalmic & Sensory20

What Makes This Valuable

  • No Competition. No metallodrug database exists anywhere. This is the only one.
  • Patent Protected. U.S. Patent Application 19/630,444 covers compositions, synthesis methods, and therapeutic applications.
  • Scientifically Validated. Cross-referenced against 10 major pharmaceutical databases including PubChem (119M compounds), ChEMBL (2.5M compounds), DrugBank, ClinicalTrials.gov, and more. Validation score: 80-87%.
  • Market Context. Cisplatin alone (one platinum compound) generates billions annually and is used in 50-70% of all cancer treatment protocols. This database contains 300 compounds across 43 elements.
  • Ready to Use. Complete synthesis parameters, elemental composition tables, molecular weights, and preparation notes for every compound.

What You Receive

  • 300 complete compound formulations with full synthesis data
  • U.S. Patent Application (assignable to buyer)
  • Cross-Reference Validation Report with 30+ scientific citations
  • 4 patent-quality technical drawings
  • Master index and categorization system
  • All source files and digital assets
  • Executed Asset Purchase Agreement with Patent Assignment

Who Should Acquire This

  • Pharmaceutical companies seeking new drug candidates
  • Biotech startups building a compound pipeline
  • Research institutions developing metal-based therapeutics programs
  • Investment groups acquiring pharmaceutical IP assets

This is an exclusive acquisition. Upon sale, all rights, patent ownership, and database assets transfer to the buyer via executed Asset Purchase Agreement.

Serious inquiries only. NDA available upon request.
Contact: crioneaka@outlook.com
Patent Application: 19/630,444 | Confirmation: 1348

MetalloDrugDB™ — 300 Compounds. 43 Elements. 15 Categories. One Database. First of Its Kind.

Acquisition Path

This product is available through CGB's 4-step acquisition path. The current price is shown in your cart and on the live storefront page.

  • Step 1 — Proof of Function: public, $1.69 each.
  • Step 2 — Mathematical Deposition: reading material under mutual NDA.
  • Step 3 — Evaluation License: hands-on evaluation under NDA; fee credits toward Step 4.
  • Step 4 — Full Acquisition:

See the acquisition path overview →

Write Your Own Review
You're reviewing:MetalloDrugDB - Complete Database Acquisition (300 Compounds)
Copyright © 2009-present Christopher Gabriel Brown. All rights reserved. "STRICT INTELLECTUAL PROPERTY NOTICE: All content, code, scripts, and styles in this file are the exclusive intellectual property of Christopher Gabriel Brown. DO NOT COPY, DISTRIBUTE, OR USE WITHOUT EXPRESS WRITTEN PERMISSION." Under no circumstance is there to be a transfer of Intellectual Property. Christopher Gabriel Brown presents a portfolio of advanced technologies across computing, energy, defense, and data systems. The site features products including the AutoPhi Quantum Processor (3.5 ExaFLOPS with quantum capabilities), Quantum Battery (unlimited energy storage with zero degradation), War Satellite (autonomous defense platform with global surveillance), Electric Jet (zero-emission supersonic propulsion), and specialized systems like nuclear waste recycling, blockchain security infrastructure, and smart wearable platforms. Each product includes complete documentation, manufacturing blueprints, patent protection, and implementation resources, positioning them as production-ready solutions for enterprise, government, and research applications. The collection spans quantum computing, renewable energy, aerospace, cybersecurity, and IoT, emphasizing innovation, patent protection, and technical depth. **Preferred Contact Methods** Christopher Gabriel Brown accepts communication by **email and postal mail only**. No phone calls please. **Email:** crioneaka@outlook.com **Mail:** 1341 Wellington Cove, Lawrenceville, GA 30043-5255, USA | USA-ONLY SALES | United States Dollars only | Email-only contact | No non-US orders accepted